Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Frequency of GBA1 and LRRK2 G2019S mutations, and body mass index in Ashkenazi Jews
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Frontal dysfunction in Tourette syndrome: A PET-FDG study
Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Functional characterisation and the selective vulnerability of SNCA (A30P) patient-derived midbrain dopaminergic neurons to ER stress
Therapy in movement disorders: Gene and cell-based therapies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gait impairment is more than a motor symptom in Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gait initiation in response to emotion-inducing pictures in Parkinson’s disease
Pathophysiology (other movement disorders) · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gender-age features of autonomic heart rhythm disturbances in Parkinson’s disease patients
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gene delivery of AAV2-neurturin for patients with Parkinson’s disease: A meta-analysis
Therapy in movement disorders: Gene and cell-based therapies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gene expression analysis using the Parkinson’s disease map reveals early effects of alpha-synuclein on PD pathogenesis
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Gene network driven probable drug target identification: An in-silico study on Parkinson’s disease
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Generation and characterization of midbrain organoids from iPSCs of familial Parkinson’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 48
- Next Page»